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Introduction 
Bronchial artery embolization is an effective therapeutic 
alternative for the treatment of severe haemoptysis, 
especially when conservative treatments fail or when 
patients are not good candidates for surgery (1). Some 
complications of bronchial artery embolization have been 
reported in the literature including chest pain, ectopic 
deposition of coil and embolization of other vessels, left 
main bronchial stenosis or infarction (2), bronchoesopha- 
geal fistula (3), spinal cord injury (4), fatal ischaemic colitis 
(5), and transient pulmonary infarction after complete 
pulmonary artery and bronchial artery embolization (6). 
There is even one report in the literature of left bronchial- 
to-coronary artery communication, seen on a follow-up 
postembolization angiogram (7), thus the potential for 
myocardial infarction with bronchial embolization also 
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exists. To our knowledge, this is the first report of cortical 




A 29-year-old male was admitted to our hospital emergency 
room because of persistent haemoptysis for 2 days. He had 
a history of pulmonary tuberculosis and underwent left 
lower lobe lobectomy for bronchiectasis in 1990, as well as 
a bronchial artery embolization for recurrent haemoptysis 
in 1991. Because of continued haemoptysis after conserva- 
tive treatments during this hospitalization, a secondary 
bronchial artery embolization was performed. Angiogram 
through bilateral bronchial arteries injection via right 
femoral artery approach revealed dilated and tortuous 
hypervascularization over the bilateral lung field, with 
blood supplied from the left inferior and right bronchial 
artery [Plate l(a) and (b)]. Embolization was performed 
with ivalon particles (250-590,~m) in 20 ml lipiodol injec- 
tion in both left inferior artery and right bronchial artery. 
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PLATE 1. (a) Left inferior bronchial angiogram showing 
dilated and tortuous hypervascularity in the left lung 
field. (b) Right bronchial angiogram showing dilated and 
tortuous hypervascularity in the right lower lung field. 
PLATE 2. (a) After left inferior bronchial artery emboliz- 
ation. (b) After right bronchial artery embolization. 
Stasis of blood flow was obtained [Plates 2(a), (b) and 31. 
However, the patient began to suffer from headache, neck 
stiffness, and bilateral loss of vision approximately 3 h after 
embolization. The pupillary response to light reflex was 
normal and there was a normal range of extraocular 
movements. There were no other abnormal neurological 
findings except neck stiffness. Brain computed tomography 
(CT) was done immediately but revealed no abnormalities. 
Cerebrospinal fluid examination was also normal. Ophthal- 
moscopy showed no evidence of central retinal artery 
occlusion. Follow-up brain CT 2 days later was unchanged. 
He completely recovered 3 days later and he was discharged 
10 days after bronchial artery embolization. 
CASE 2 
A 22-year-old female with pulmonary tuberculosis was 9 ml lipiodol injected slowly via the right bronchial artery. 
admitted via the emergency room with severe haemoptysis Stasis of right bronchial artery flow was obtained. How- 
during the previous 24 h. Because of uncontrolled haemo- ever, the patient began to complain of severe headache and 
ptysis following medical treatment, a bronchial artery bilateral loss of vision approximately 3 h after emboliza- 
embolization was performed. A selective right bronchial tion. The findings of neurological examination were normal 
artery angiogram demonstrated hypervascularity with except for bilateral loss of vision. The findings of brain CT 
dilated and tortuous bronchial artery branches. Emboliza- were normal. Ophthalmoscopy showed no evidence of 
tion was performed with ivalon particle (250-590,~m) and central retinal artery occlusion. Her symptoms and signs 
PLATE 3. Chest roentogenogram just after left inferior 
and right bronchial arteries embolization. 
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disappeared 2 days later and she finally was discharged in 
stable condition 7 days after bronchial artery embolization. 
Discussion 
Several mechanisms have been postulated to be responsible 
for ischaemia of structures adjacent to bronchial arteries 
following bronchial artery embolization, including emboli- 
zation of blood supply to the proximal bronchus, occlusion 
of the capillary bed by small embolic particles, and reflux of 
the embolic agent into adjacent vessels (2-6). But these 
mechanisms cannot completely explain the ischaemia of 
distant structures following bronchial artery embolization. 
Embolic agents, such as gelfoam, absolute alcohol, ivalon, 
and isobutyl-2-cyanoarcylate have been reported to cause 
ischaemic complication in adjacent structures. These liquid 
agents or small particles can cause tissue infarction of 
adjacent structures due to distal vascular occlusion. When 
right to left shunting is present, these liquid agents or small 
particles can also embolize into the systemic circulation to 
cause distant structure ischaemia. Therefore, embolic par- 
ticles should be at least 200-300,~m in size and larger 
(300-500 pm) when shunting is identified on the diagnostic 
angiogram (89). In the two cases, ivalon particle is 2% 
590,~m in size and no shunting can be visible on the angio- 
gram. The lipiodol may have more potential than ivalon 
to pass abnormal shunting into the systemic circulation 
causing ischaemia in distant structures. 
The two patients in this report presented with transient 
bilateral loss of vision and headache approximately 3 h 
after bronchial artery embolization and recovered 223 days 
later. Because the patients’ symptoms were bilateral loss of 
vision and associated with other cerebral manifestations, 
and because central retinal artery occlusion was not seen 
on the ophthalmoscopic examination, the possibility of 
bilateral central retinal arteries occlusion is unlikely. 
Although the findings of brain CT were normal in both 
patients, we believe that the embolic of ivalon/lipiodol are 
the main causes of the cortical blindness. It is hypothesized 
that the cortical blindness developed because of embolism 
of the particles to the occipital cortex in both hemispheres, 
either through a bronchial artery to pulmonary vein con- 
nection or through collaterals between the bronchial and 
vertebral arteries. The latter is more likely, as the postulated 
emboli are localized in the same arterial territory in both 
patients. The process of neovascularity can occur in lung 
inflammation and the neovascularity may arise from other 
adjacent collateral pathways or different arterial source 
vessels. Communication via collaterals to the vertebral 
arteries can occur and has been demonstrated at the time of 
angiographic study/embolization by Irvin F. Hawkins. 
Embolic agents can reflux into these collaterals at the time 
of embolization, especially with bolus delivery of the 
embolic agents. Once the agents enter these vertebral artery 
collaterals, they then enter into the vertebral-basilar system 
and into the posterior cerebral artery distribution where 
cortical blindness can result as a sequlae. There is one 
report in the literature of bilateral transient cortical blind- 
ness due to emboli during coronary and graft angiography. 
Vertebral angiography was performed in the first patient 
and the appearances were compatible with multiple emboli 
in the vertebral-basilar circulation, occurring as a result of 
manipulation of the guidewire close to the left vertebral 
artery. The first patient’s vision recovered within 72 h and 
all neurological deficits also resolved later. The second 
patient’s vision recovered fully within 15 minutes (10). 
Both patients developed headache with one also having 
neck stiffness. Such reactions are not typical in the setting 
of cerebral ischaemia. The embolization may be unlikely to 
be the sole mechanism of the cerebral manifestations and 
vasospasm (1 I), contrast neurotoxicity (12) and toxic tissue 
reaction of embolic particles (13) have been invoked as 
possible explanations. Light microscopic and immunohisto- 
chemical examination showed distinct patterns of tissue 
reaction to multiple embolic agents which were used in 
embolotherapy for arteriovenous malformations of the 
brain. Aritene produced the mildest tissue response but 
resulted in relatively early endothelialization and recanali- 
zation. Cyanoacrylates were longer-lasting but associated 
with more acute and chronic inflammation and vessel wall 
changes. lvalonlethanol mixture had intermediate proper- 
ties (13). Tissue ischaemia within the embolized region, 
together with toxic effects, may promote necrosis of vessel 
walls and adventitial tissue, and leakage of embolic into the 
adventia. The nature and extent of these changes will vary 
not only with the with location and amount of embolic 
injected, but with their type (14). The ivalonllipiodol used in 
the two patients do not belong to the same batch and 
contamination is not likely during the whole course. The 
emboli of ivalonllipidol may produce similar localized or 
generalized toxic tissue reactions which probably induce 
headache and neck stiffness. 
Although using lipiodol to embolize the bronchial artery 
is an unsafe manipulation in this report, the cortical blind- 
ness is an important and potentially morbid complication 
following bronchial artery embolization that has not been 
significantly addressed in the literature to date. 
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Introduction 
Anti-aminoacyl t-RNA antibodies (anti-Jol, PL-7, PL-12, 
EJ, OJ and KJ) are evident in over a quarter of patients 
with polymyositis, dermatomyositis or idiopathic inflam- 
matory myositis (1). Over two thirds of such patients have 
interstitial lung disease (ILD) (1). The anti-synthetase anti- 
body (ASA) syndrome comprises various combinations of 
ILD, fever, inflammatory myositis, symmetric inflamma- 
tory arthritis, Raynauds phenomenon (RP) and mechanics 
hands (2,3). These may occur in any temporal sequence and 
some features may be more prominent than others. Myo- 
sitis is evident in the majority of patients. However, disease 
prognosis is determined by the severity and rate of progres- 
sion of the ILD (3). Pulmonary histology generally confirms 
an interstitial fibro-inflammatory process (4). While respir- 
atory symptoms often develop over many weeks occasional 
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patients have presented with rapidly progressive lung dis- 
ease or the adult respiratory distress syndrome (1). Among 
these latter patients some have had little obvious myositis 
(1). We describe a patient with a fatal respiratory illness of 
rapid onset in whom anti-Jo antibodies were associated 
with a pulmonary vasculitis but no overt myositis. 
Case Report 
A previously well 60-year-old Caucasian female presented 
with pleuritic chest pain and a 2 week history of progressive 
dyspnoea, fever, non-productive cough and arthralgia of 
the hands and feet. She denied recent overseas travel and 
occupational exposure to allergens or toxic substances. Her 
past medical history included hypertension, mild episodic 
asthma and hypothyroidism. There was no significant fam- 
ily history and the patient was a non-smoker. Her medica- 
tions were thyroxine, frusemide and atenolol and inhaled 
salbutamol, ipratropium bromide and betamethasone. 
On examination she was pyrexial (38”C), hypotensive 
(blood pressure 100165) and hypoxaemic (0, saturation 
92% on 28% mask oxygen). Bibasal inspiratory crackles 
